Evidence map›Paper›PMID 28361523›Full record

ArticleCancer research and treatment2018

Nationwide Statistical Analysis of Lymphoid Malignancies in Korea.

Hyewon Lee, Hyeon Jin Park, Eun-Hye Park, Hee Young Ju, Chang-Mo Oh, Hyun-Joo Kong, Kyu-Won Jung, Byung-Kiu Park, Eunyoung Lee, Hyeon-Seok Eom and 1 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer research and treatment, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. The Relationships between Physical Activity, Exercise, and Sport on the Immune System.International journal of environmental research and public health · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Hyewon LeeCenter for Hematologic Malignancy, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Hyeon Jin ParkCenter for Pediatric Oncology, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Eun-Hye ParkCancer Registration and Statistics Branch, National Cancer Center, Goyang, Korea.
Hee Young JuCenter for Pediatric Oncology, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Chang-Mo OhCancer Registration and Statistics Branch, National Cancer Center, Goyang, Korea.
Hyun-Joo KongCancer Registration and Statistics Branch, National Cancer Center, Goyang, Korea.
Kyu-Won JungCancer Registration and Statistics Branch, National Cancer Center, Goyang, Korea.
Byung-Kiu ParkCenter for Pediatric Oncology, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Eunyoung LeeCenter for Hematologic Malignancy, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Hyeon-Seok EomCenter for Hematologic Malignancy, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Young-Joo WonCancer Registration and Statistics Branch, National Cancer Center, Goyang, Korea.
National Cancer Center · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeRegional differences in the incidence of lymphoid malignancies have been reported worldwide, but there has been no large-scale epidemiologic analysis in Korea. The aim of this study was to provide a nationwide population-based statistical analysis of Korean patients with lymphoid malignancies. MATERIALS AND

methodsThe Korea Central Cancer Registry analyzed the incidence and survival of patients with lymphoid malignancies from the Korean National Cancer Incidence Database. Diseases were grouped by clinically relevant categories based on the 2008 World Health Organization classification.

resultsOverall 65,948 lymphoid diseases were identified between 1999 and 2012. The incidence of most subtypes increased with age, except for precursor cell neoplasms. Male predominance (male:female ratio=1.28:1) was observed. In 2012, annual age-standardized incidence rates per 100,000 persons of Hodgkin's lymphoma, mature B-cell neoplasm, mature T/natural killer (NK)-cell neoplasm, and precursor cell neoplasm were 0.46, 6.60, 0.95, and 1.50, respectively, and they increased yearly from 1999. Composite Hodgkin's and non-Hodgkin's lymphomas were extremely rare. Survival improvement estimated using 5-year relative survival rate was observed in patients with Hodgkin's lymphoma (71.1%-83.0%), diffuse large B-cell lymphoma (49.5%-61.5%), plasma cell neoplasms (20.2%-36.9%), and lymphoblastic lymphoma/leukemia (41.5%-56.3%) between 1993 and 2012. However, survival rates of T/NK-cell lymphoma (excluding cutaneous T-cell lymphoma) ranged from 40.5%-43.5% during the study period. Survival rates decreased with age in most subtypes.

conclusionThis report presented the subtype-specific statistical analysis of lymphoid malignancies in the Korean population, showing increasing incidences and survival rates in most subtypes.

Indexed as

FemaleHodgkin DiseaseHumansIncidenceLymphoma, Non-HodgkinMaleRepublic of KoreaSurvival RateEpidemiologyHematologic neoplasmsIncidenceRepublic of KoreaSurvival

Identifiers

PMID28361523
PMCPMC5784621
OpenAlexW2602632746

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.